查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1990510

冠狀動脈繞道手術手術器械市場：依產品類型、移植類型、手術類型和最終用戶分類－2026-2032年全球市場預測

Coronary Artery Bypass Graft Devices Market by Product Type, Graft Type, Procedure Type, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，冠狀動脈繞道手術手術裝置市場價值將達到 158.6 億美元，到 2026 年將成長至 168.1 億美元，到 2032 年將達到 249.2 億美元，複合年成長率為 6.66%。

主要市場統計數據
基準年 2025 158.6億美元
預計年份：2026年 168.1億美元
預測年份 2032 249.2億美元
複合年成長率 (%) 6.66%

這是一份清晰權威的冠狀動脈繞道手術手術裝置市場趨勢分析報告，系統性地闡述了臨床重點、技術進步和相關人員的期望。

冠狀動脈繞道手術手術器械領域在心血管外科手術中扮演著核心角色，它需要在既有的外科手術實踐與持續的技術進步之間尋求平衡。臨床醫生繼續依賴成熟的技術，而器械製造商和醫療系統則致力於推進漸進式和顛覆性創新，以提高手術安全性、減少手術全期手術期併發症並縮短恢復時間。在此背景下，相關人員如今將臨床療效、易用性和供應鏈韌性視為影響器材應用決策的同等重要因素。

臨床偏好的變化、技術整合以及供應鏈韌性如何共同重塑冠狀動脈繞道手術 (CABG) 治療中的設備選擇、部署和籌資策略？

冠狀動脈繞道手術手術器械領域正經歷著變革性的轉變，這主要歸因於臨床、技術和操作等多方面因素的共同作用。微創手術和非體外循環技術的出現，刺激了對專用吻合器和穩定器的需求，這些器械和穩定器旨在提高在有限手術視野下操作的精確度。同時，心肺體外迴圈系統的改進也更加重視便攜性、生物相容性和降低發炎反應。這些趨勢正在重新定義手術室和心臟中心的採購標準，促使醫療機構在評估資本投資時，權衡預期的臨床效益和工作流程效率。

評估美國在 2025 年實施的關稅措施對 CABG 器械供應鏈選擇、製造本地化和採購慣例的累積影響。

美國於2025年推出的關稅政策對冠狀動脈繞道手術手術（CABG）器械的價值鏈產生了累積影響，迫使製造商和買家重新評估其供應商和製造地。關稅的分階段上調提高了進口器械組件和成品的接收成本，進而影響了醫院和門診手術中心的採購決策。為因應這一變化，多家國際供應商調整了其商業策略，採取了擴大區域生產能力、重新談判供應商合約以及加快對本地組裝業務的投資等措施，以保持競爭力。

多方面的細分洞察，解釋了產品類型、移植選擇、手術方式和最終用戶趨勢如何影響設備的開發、採用和採購。

冠狀動脈繞道手術手術器械領域的細分揭示了創新、臨床偏好和採購優先事項的交匯點。根據產品類型，該領域包括吻合器、心肺體外迴圈系統、鉗夾和閉塞器以及穩定器。吻合器進一步細分為壓迫式吻合環和縫合器；心肺體外迴圈系統細分為可攜式系統和標準心肺體外迴圈系統；鉗夾和閉塞器細分為主動脈鉗和血管閉塞器；穩定器為機械穩定器和吸力穩定器器。這種產品層面的細分使相關人員能夠將手術要求與器械功能相匹配，並評估一次性便利性和可重複使用設備之間的權衡。

美洲、歐洲、中東和非洲以及亞太地區的趨勢和採用情況存在區域差異，這正在影響臨床實踐和供應商策略。

區域趨勢對冠狀動脈繞道手術手術裝置的臨床實務模式、監管路徑和籌資策略有顯著影響。在美洲，臨床中心通常需要在高度發展的三級醫療網路和多樣化的採購模式之間取得平衡，這些模式涵蓋了從集中式聯合採購組織到醫院層面採購等多種模式，從而為能夠提供臨床證據和服務支援的供應商創造了競爭環境。在歐洲、中東和非洲，監管協調的努力、多樣化的報銷環境以及醫院能力的差異導致了器械應用方面的差異。一些高容量醫療機構正在推動臨床創新，而另一些機構則優先考慮成本控制和器材可靠性。

競爭與合作並存的企業動態凸顯了成熟企業、專業創新者和新參與企業如何推動產品演進、臨床試驗和商業性差異化。

冠狀動脈繞道手術手術器材領域的競爭動態呈現出多元化的態勢，既有成熟的跨國醫療設備公司，也有專注於特定領域的創新專業外科器材企業，以及靈活敏捷、致力於創新的Start-Ups。成熟的醫療設備製造商憑藉著廣泛的臨床關係、完善的服務網路和豐富的監管經驗，維持其市場主導地位。同時，專業公司則在吻合器技術、微創穩定裝置和新一代灌注系統等領域競爭。這種競爭平衡推動產品持續改進、臨床證據不斷累積以及針對性培訓計畫的發展，從而確保產品在外科團隊中佔據優先地位。

能夠幫助製造商和醫療保健系統加快臨床部署的切實有效的策略，增強醫療設備的韌性，並加強以價值主導的採購成果。

產業領導者應優先考慮一系列切實可行的策略，以協調產品開發、臨床應用和供應鏈韌性。首先，應利用多中心和註冊研究，投資產生將手術結果與特定器械獲益聯繫起來的證據，並建立引人入勝的臨床案例。其次，應在產品設計中考慮模組化和互通性，以滿足對整合式手術室生態系統和數據驅動型性能監測日益成長的需求。這些產品特性可以減少臨床實務中的摩擦，並有助於醫療採購決策。

我們透過穩健透明的調查方法確保合法性，該方法結合了相關人員訪談、臨床註冊分析、監管審查和供應鏈評估。

本研究整合一手和二手資料，以確保結論和建議的證據全面且可重複。一手數據將透過對心臟外科醫師、循環系統護理師、醫院採購經理和醫療設備工程師進行結構化訪談獲得，以了解手術偏好、對醫療設備性能的認知以及採購考量。除這些定性研究結果外，還將分析臨床註冊資料、同行評審的臨床試驗報告和監管申報文件，以全面檢驗醫療設備的安全性、手術結果和上市後監測訊號。

整合臨床、技術和營運要求，為冠狀動脈繞道手術 (CABG) 治療中醫療設備的引進、創新和策略夥伴關係制定未來發展路徑。

冠狀動脈繞道手術手術（CABG）器械生態系統正處於臨床創新、監管和供應鏈策略交匯的十字路口。外科團隊不斷改善手術流程，而器械開發商則積極回應，推出針對性創新，以增強手術控制、減輕生物負擔並提高手術效率。同時，關稅措施、報銷方案調整和醫院採購優先事項等外部壓力，迫使製造商在產品生產地點和方式、定價以及售後支援等方面做出更謹慎的決策。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：冠狀動脈繞道手術手術器械市場：依產品類型分類

  • 吻合裝置
    • 壓迫吻合環
    • 訂書機
  • 心肺體外迴圈系統
    • 可攜式系統
    • 標準體外循環機
  • 夾具和封口
    • 主動脈鉗夾
    • 血管阻塞器
  • 固定裝置
    • 機械固定裝置
    • 吸力固定器

第9章：冠狀動脈繞道手術手術器械市場（依移植類型分類）

  • 動脈移植
    • 乳內動脈
    • 橈動脈
  • 靜脈移植

第10章：依手術方式冠狀動脈繞道手術手術器械市場

  • 非泵送
  • 泵浦上

第11章冠狀動脈繞道手術手術器械市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第12章冠狀動脈繞道手術手術器械市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章冠狀動脈繞道手術手術器械市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章冠狀動脈繞道手術手術器械市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國冠狀動脈繞道手術手術器械市場

第16章：中國冠狀動脈繞道手術手術器械市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Artivion, Inc.
  • AtriCure, Inc.
  • B. Braun SE
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • KLS Martin Group
  • LeMaitre Vascular, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vascular Solutions, Inc.
  • WL Gore & Associates, Inc.
Product Code: MRR-6A132FD325F8

The Coronary Artery Bypass Graft Devices Market was valued at USD 15.86 billion in 2025 and is projected to grow to USD 16.81 billion in 2026, with a CAGR of 6.66%, reaching USD 24.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.86 billion
Estimated Year [2026] USD 16.81 billion
Forecast Year [2032] USD 24.92 billion
CAGR (%) 6.66%

A clear and authoritative orientation to the coronary artery bypass graft device landscape that frames clinical priorities technological evolution and stakeholder expectations

The coronary artery bypass graft device domain occupies a central role in cardiovascular surgery, balancing established surgical practice with persistent technological evolution. Clinicians continue to rely on proven techniques while device manufacturers and healthcare systems pursue incremental and disruptive innovations that improve procedural safety, reduce perioperative morbidity, and shorten recovery timelines. Against this backdrop, stakeholders now weigh clinical outcomes, ease of use, and supply chain resilience as equally important determinants of adoption decisions.

Recent advances in materials science, device ergonomics, and perfusion technology have reshaped clinical workflows, enabling teams to refine operative strategies and expand the treatment population. At the same time, regulatory scrutiny and payer requirements are prompting manufacturers to demonstrate robust evidence of procedural benefit and device reliability. As a result, the landscape is increasingly defined by the interplay of surgical technique preference, device capability, and institutional capacity to integrate new technologies into complex care pathways.

How clinical preference shifts technological integration and supply chain resilience are jointly reshaping device selection adoption and procurement strategies in CABG care

The landscape for coronary artery bypass graft devices is undergoing transformational shifts driven by converging clinical, technological, and operational forces. Minimally invasive approaches and off-pump techniques have stimulated demand for specialized anastomosis devices and stabilizers designed to facilitate precision in constrained operative fields, while improvements in cardiopulmonary bypass systems emphasize portability, biocompatibility, and reduced inflammatory response. These trends have redefined procurement criteria for surgical suites and cardiac centers, prompting institutions to evaluate capital acquisition against anticipated clinical gains and workflow efficiency.

Parallel to clinical innovation, digital augmentation and the rise of integrated operating room platforms are changing the expectations for device interoperability. Surgeons and perfusionists increasingly expect devices that support data capture, intraoperative visualization, and post-operative performance analytics. Consequently, manufacturers are investing in modular designs and connectivity features that enable better integration with hospital information systems and procedural analytics. Supply chain strategies have also adapted, with a renewed emphasis on dual-sourcing, localized manufacturing, and inventory optimization to mitigate disruptions and meet heightened regulatory compliance demands.

Assessment of the cumulative effects of the 2025 United States tariff measures on supply chain choices manufacturing localization and procurement practices for CABG devices

United States tariff policy introduced in 2025 has had a cumulative impact on coronary artery bypass graft device value chains, compelling manufacturers and purchasers to reassess sourcing and manufacturing footprints. Tariff escalation increased landed costs for imported device components and finished goods, which in turn affected procurement decisions across hospitals and ambulatory surgical centers. In response, several international suppliers recalibrated their commercial strategies by expanding regional manufacturing capacity, renegotiating supplier agreements, and accelerating investments in local assembly operations to preserve competitiveness.

Clinicians and hospital purchasing teams experienced operational implications as procurement windows tightened and lead-time variability increased. Some institutions prioritized devices with established local supply or those produced by manufacturers with nearshore facilities to ensure continuity of care. At a policy and industry level, there was a marked increase in dialogue between trade policymakers, medical device associations, and hospital consortia to explore tariff exemptions for clinical-critical components and to identify opportunities for incentivizing domestic production. The net effect has been a more intentional approach to supply chain risk management and a renewed focus on bilateral supplier relationships that balance cost, reliability, and regulatory compliance.

Multidimensional segmentation insights explaining how product type graft selection procedural modality and end user dynamics influence device development adoption and procurement

Segmentation of the coronary artery bypass graft device domain illuminates where innovation, clinical preference, and procurement focus converge. Based on Product Type, the landscape comprises Anastomosis Devices, Cardiopulmonary Bypass Systems, Clamps & Occluders, and Stabilizers, with Anastomosis Devices further distinguished by Compression Anastomosis Rings and Stapling Devices, Cardiopulmonary Bypass Systems subdivided into Portable Systems and Standard Heart-Lung Machines, Clamps & Occluders categorized into Aortic Clamps and Vascular Occluders, and Stabilizers segmented into Mechanical Stabilizers and Suction Stabilizers. This product-level granularity helps stakeholders match procedural requirements to device capabilities and assess trade-offs between single-use convenience and reusable capital equipment.

Based on Graft Type, the clinical and procurement conversation differentiates Arterial Grafts and Venous Grafts, with Arterial Grafts further examined through Internal Mammary Artery and Radial Artery use cases, and Venous Grafts represented primarily by the Saphenous Vein. These graft distinctions influence surgeon technique, device selection for anastomosis delivery, and perioperative management protocols. Based on Procedure Type, the dichotomy between Off-Pump and On-Pump approaches continues to shape the adoption curve for certain devices, as off-pump cases place a premium on stabilizers and anastomosis solutions that perform reliably in a beating-heart environment, while on-pump procedures create different perfusion and clamp requirements.

Based on End User, device adoption and purchasing dynamics diverge between Ambulatory Surgical Centers and Hospitals, with ambulatory settings often prioritizing devices that enable rapid turnover and simplified workflows, whereas hospitals weigh long-term capital utilization, support contracts, and cross-procedural versatility. Together, these segmentation lenses provide a multidimensional view that informs product development priorities, clinical training initiatives, and procurement negotiations.

Regional dynamics and differentiated adoption profiles across the Americas Europe Middle East Africa and Asia-Pacific shaping clinical practice and supplier strategy

Regional dynamics exert a strong influence on clinical practice patterns, regulatory pathways, and procurement strategies for coronary artery bypass graft devices. In the Americas, clinical centers often balance highly developed tertiary care networks with diverse procurement models that range from centralized group purchasing organizations to hospital-level sourcing, creating a competitive environment for suppliers that can provide clinical evidence and service support. In Europe, Middle East & Africa, regulatory harmonization efforts, varying reimbursement environments, and heterogeneous hospital capabilities shape differentiated adoption profiles where some high-volume centers lead clinical innovation while others prioritize cost containment and device reliability.

Across the Asia-Pacific region, rapid expansion of cardiovascular care capacity, investment in tertiary centers, and government-led manufacturing initiatives have reshaped demand patterns. Local manufacturing incentives, coupled with active clinical training programs, have accelerated adoption of both standard and portable cardiopulmonary systems. Transitional economies within the region balance access constraints with growing procedural volumes, which encourages suppliers to tailor commercial models that include managed services, training partnerships, and flexible financing. These regional distinctions highlight the necessity for manufacturers to adopt segmented go-to-market strategies that align clinical engagement, after-sales service, and regulatory expertise with local health system priorities.

Competitive and collaborative company dynamics highlighting how incumbents specialized innovators and new entrants drive product evolution clinical adoption and commercial differentiation

Competitive dynamics in the coronary artery bypass graft device arena reflect a mix of established multinational medical device corporations, specialized surgical device innovators, and agile startups introducing focused innovations. Established device manufacturers leverage extensive clinical relationships, integrated service networks, and regulatory experience to maintain installed base advantages, while specialized firms compete on innovation in staple anastomosis technologies, minimally invasive stabilizers, and next-generation perfusion systems. This competitive balance drives a continuous cycle of product refinement, clinical evidence generation, and targeted training programs to secure preference within surgical teams.

Strategic activity includes partnerships between device firms and hospital systems to pilot new technologies and collect real-world performance data, licensing agreements that broaden device availability, and vertical integration moves that bring consumables and capital equipment under common service contracts. Competitive pressure also incentivizes investment in value-added services such as remote device monitoring, clinician training modules, and consumable management. For new entrants, differentiation often hinges on demonstrating procedural efficiency, ease of adoption, and robust post-market clinical data that resonates with both surgeons and institutional procurement committees.

Practical high-impact strategies for manufacturers and health systems to accelerate clinical adoption enhance device resilience and strengthen value-driven procurement outcomes

Industry leaders should prioritize a set of actionable strategies to align product development, clinical adoption, and supply chain resilience. First, invest in evidence generation that couples procedural outcomes with device-specific advantages, leveraging multicenter clinical collaborations and registry-based studies to create compelling clinical narratives. Second, design products with modularity and interoperability in mind to meet the growing demand for integrated operating room ecosystems and data-driven performance monitoring. These product attributes reduce friction at the point of care and facilitate institutional procurement decisions.

Third, adopt supply chain diversification strategies that balance cost optimization with redundancy, including regional assembly, multiple qualified component suppliers, and scalable inventory management to address tariff-related uncertainties and logistical disruptions. Fourth, engage early and consistently with clinical champions and perfusion teams to build training curricula and onboarding programs that shorten the learning curve for new devices. Finally, explore commercial models that go beyond transactional sales-service contracts, outcome-based pricing pilots, and managed device programs can align incentives with health systems and create longer-term value. Together, these actions help manufacturers and healthcare providers navigate a rapidly evolving clinical and regulatory environment while preserving procedural quality and institutional budgets.

Robust and transparent research methodology combining stakeholder interviews clinical registry analysis regulatory review and supply chain evaluation to ensure defensible insights

This research synthesizes primary and secondary evidence sources to ensure a comprehensive, reproducible basis for conclusions and recommendations. Primary inputs include structured interviews with cardiac surgeons, perfusionists, hospital procurement leaders, and device engineers to capture procedural preferences, device performance perceptions, and procurement considerations. These qualitative insights were supplemented by analysis of clinical registries, peer-reviewed clinical trial reports, and regulatory filings to triangulate device safety profiles, procedural outcomes, and post-market surveillance signals.

Secondary research comprised a systematic review of relevant clinical literature, technical whitepapers, and manufacturer product specifications to map device feature sets and technological trajectories. Supply chain and trade policy analysis integrated customs and tariff schedules, public trade notices, and manufacturing investment announcements to assess sourcing implications. Data synthesis involved cross-validation of clinical claims against registry outcomes and reconciliation of stakeholder perspectives with documented regulatory events, producing a balanced and defensible understanding of device dynamics and strategic implications.

Synthesis of clinical technological and operational imperatives that define future pathways for device adoption innovation and strategic partnership in CABG care

The coronary artery bypass graft device ecosystem is at an inflection point where clinical innovation, regulatory scrutiny, and supply chain strategy intersect. Surgical teams continue to refine procedural techniques while device developers respond with targeted innovations that enhance procedural control, reduce physiological insult, and improve operational efficiency. At the same time, external pressures such as tariff measures, reimbursement dynamics, and hospital procurement priorities compel manufacturers to be more deliberate in where and how they manufacture, price, and support their products.

Looking forward, stakeholders who prioritize clinical evidence generation, device interoperability, and supply chain resilience will be better positioned to influence adoption decisions and sustain long-term partnerships with health systems. Cross-sector collaboration among clinicians, manufacturers, and payers will be essential to align technological potential with patient-centered outcomes and institutional imperatives. Ultimately, the most successful organizations will be those that combine technical excellence with pragmatic commercial models and demonstrable real-world performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Coronary Artery Bypass Graft Devices Market, by Product Type

  • 8.1. Anastomosis Devices
    • 8.1.1. Compression Anastomosis Rings
    • 8.1.2. Stapling Devices
  • 8.2. Cardiopulmonary Bypass Systems
    • 8.2.1. Portable Systems
    • 8.2.2. Standard Heart-Lung Machines
  • 8.3. Clamps & Occluders
    • 8.3.1. Aortic Clamps
    • 8.3.2. Vascular Occluders
  • 8.4. Stabilizers
    • 8.4.1. Mechanical Stabilizers
    • 8.4.2. Suction Stabilizers

9. Coronary Artery Bypass Graft Devices Market, by Graft Type

  • 9.1. Arterial Grafts
    • 9.1.1. Internal Mammary Artery
    • 9.1.2. Radial Artery
  • 9.2. Venous Grafts

10. Coronary Artery Bypass Graft Devices Market, by Procedure Type

  • 10.1. Off-Pump
  • 10.2. On-Pump

11. Coronary Artery Bypass Graft Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Coronary Artery Bypass Graft Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Coronary Artery Bypass Graft Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Coronary Artery Bypass Graft Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Coronary Artery Bypass Graft Devices Market

16. China Coronary Artery Bypass Graft Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Artivion, Inc.
  • 17.7. AtriCure, Inc.
  • 17.8. B. Braun SE
  • 17.9. BIOTRONIK SE & Co. KG
  • 17.10. Boston Scientific Corporation
  • 17.11. Cardinal Health, Inc.
  • 17.12. CryoLife, Inc.
  • 17.13. Edwards Lifesciences Corporation
  • 17.14. Getinge AB
  • 17.15. KLS Martin Group
  • 17.16. LeMaitre Vascular, Inc.
  • 17.17. LivaNova PLC
  • 17.18. Medtronic PLC
  • 17.19. Merit Medical Systems, Inc.
  • 17.20. MicroPort Scientific Corporation
  • 17.21. Teleflex Incorporated
  • 17.22. Terumo Corporation
  • 17.23. Vascular Solutions, Inc.
  • 17.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COMPRESSION ANASTOMOSIS RINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STAPLING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STANDARD HEART-LUNG MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AORTIC CLAMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VASCULAR OCCLUDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY MECHANICAL STABILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUCTION STABILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY INTERNAL MAMMARY ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY RADIAL ARTERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY VENOUS GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY OFF-PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ON-PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 168. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 171. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 198. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 201. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 211. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ANASTOMOSIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CARDIOPULMONARY BYPASS SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY CLAMPS & OCCLUDERS, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY STABILIZERS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY ARTERIAL GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CORONARY ARTERY BYPASS GRAFT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)